Host-derived intracellular immunization against mouse hepatitis virus infection

Virology

Volumn 228, Issue 2, 1997, Pages 318-332

  Chen, Wan ^a   Madden, Victoria J ^a   Bagnell Jr , C Robert ^a   Baric, Ralph S ^a  

^a IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE RECEPTOR; VIRUS VACCINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; GENE EXPRESSION; GENE TRANSFER; IMMUNIZATION; IMMUNOFLUORESCENCE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS;

EID: 0031575512     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8402     Document Type: Article

References (75)

1. Andrews N. C., Baltimore D. Purification of a terminal uridylytransferase that acts as a host factor for the in vitro poliovirus replicase reaction. Proc. Natl. Acad. Sci. USA. 83:1986;221-225.
2. Asanaka M., Lai M. M. C. Cell fusion studies identified multiple cellular factors involved in mouse hepatitis virus entry. Virology. 197:1993;732-741.
3. Baltimore D. Intracellular immunization. Nature. 335:1988;395-396.
4. Baric R. S., Lineberger D. W., Johnston R. E. Reduced synthesis of sindbis negative strand RNA in cultures treated with host transcription inhibitors. J. Virol. 47:1982;46-54.
5. Baric R. S., Fu K. S., Schaad M. M. C., Stohlman S. A. Establishing a genetic recombination map of MHV-A59 complementation groups. Virology. 177:1990;646-656.
6. Boyle J. F., Weismiller D. G., Holmes K. V. Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J. Virol. 61:1987;185-189.
7. Buonocore L., Rose J. K. Blockade of human immunodeficiency virus type 1 production in CD4+ cells by an intracellular CD4 expressed under control of the viral long terminal repeat. Proc. Natl. Acad. Sci. USA. 90:1993;2695-2699.
8. Buonocore L., Rose J. K. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature. 345:1990;625-628.
9. Burns J. W., Siadat-Pajouh M., Krishnaney A. A., Greenberg H. B. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science. 272:1996;104-107.
10. Chaplan M., Matlin K. S. Sorting of membrane and secretory proteins in polarized epithelial cells. Functional Epithelial Cells in Culture. 1989;A. R. Liss, New York. p. 71-127.
11. Cerneus D. P., Strous G. J., Van der Ende A. Bidirectional transcytosis determines the steady state distribution of the transferrin receptor at opposite plasma membrane domains of BeWo cells. J. Cell Biol. 122:1993;1233-1230.
12. Chen D. S., Asanaka M., Yokomori K., Wang F-I., Hwang S. B., Li H-P., Lai M. M. C. Pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc. Natl. Acad. Sci. USA. 92:1995;12095-12099.
13. Chen W., Baric R. S. Function of a 5′-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro. J. Virol. 69:1995;7529-7540.
14. Chen W., Baric R. S. Molecular anatomy of mouse hepatitis virus persistence: Coevolution of increased host cell resistance and virus virulence. J. Virol. 70:1996;3947-3960.
15. Compton S. R. Enterotropic strains of mouse coronavirus differ in their use of murine carcinoembryonic antigen-related glycoprotein receptors. Virology. 203:1994;197-201.
16. Dawkins R., Krebs J. R. Arms races between and within species. Proc. R. Soc. London Ser. B. 205:1979;489-511.
17. Delmas B., Gelfi J., L'Haridon R., Vogel L. K., Sjostrom H., Noren O., Laude H. Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV. Nature (London). 357:1992;417-420.
18. Delmas B., Kut E., Gelfi J., Laude H. Overexpression of TGEV cell receptor impairs the production of virus particles. Adv. Exp. Med. Biol. 380:1995;379-385.
19. Dveksler G. S., Basile A. A., Cardellichio C. B., Holmes K. V. Mouse hepatitis virus receptor activities of an MHVR/mph chimera and MHVR mutants lacking N-linked glycosylation of the N-terminal domain. J. Virol. 69:1995;543-546.
20. Dveksler G. S., Dieffenbach C. W., Cardellichio C. B., McCuaig K., Pensiero M. N., Jiang G.-S., Beauchemin N., Holmes K. V. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67:1993;1-8.
21. Dveksler G. S., Pensiero M. N., Cardellichio C. B., Williams R. K., Jiang G.-S., Holmes K. V., Dieffenbach C. W. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:1991;6881-6891.
22. Dveksler G. S., Pensiero M. N., Dieffenbach C. W., Cardellichio C. B., Basile A. A., Ella P. E., Holmes K. V. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. USA. 90:1993;1716-1720.
23. Enjuanes L., Smerdou C., Castilla J., Anton I. M., Torres J. M., Sola I., Golvano J., Sanchez J. M., Pintado B. Development of protection against coronavirus induced diseases. Adv. Exp. Med. Biol. 380:1995;197-211.
24. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. HIV-1 entry cofactor: Functional cDNA cloning of a seven transmembrane, G protein-coupled receptor. Science. 272:1996;872-877.
25. Fitchen J. H., Beachy R. N. Genetically engineered protection against viruses in transgenic plants. Annu. Rev. Microbiol. 47:1993;739-763.
26. Friedman A. D., Triezenberg S. J., McKnight S. L. Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus. Nature (London). 335:1988;452-454.
27. Gallagher T. M. Overexpression of the MHV receptor: effect on progeny virus secretion. Adv. Exp. Med. Biol. 380:1995;331-336.
28. Graves P. J., Olson K. E., Higgs S., Powers A. M., Beaty B. J., Blair C. D. Pathogen-derived resistance to Dengue type 2 virus in mosquito cells by expression of the premembrane coding region of the viral genome. J. Virol. 70:1996;2132-2137.
29. Griffiths G., Rottier P. Cell biology of viruses that assemble along the biosynthetic pathway. Semin. Cell Biol. 3:1992;367-381.
30. Hirano N., Fujiwara K., Hino S., Matumoto M. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44:1974;298-302.
31. Holmes K. V., Doller E. W., Sturman L. S. Tunicamycin resistant glycoprotein of coronavirus glycoprotein: Demonstration of a novel type of viral glycoprotein. Virology. 115:1981;334-344.
32. Hseih J-T., Luo W., Song W., Wang Y., Kleinerman D. I., Van N. T., Lin S-H. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res. 55:1995;190-197.
33. Hubbard A. L., Stieger B., Bartles J. R. Biogenesis of endogenous plasma membrane proteins in epithelial cells. Annu. Rev. Physiol. 51:1989;555-570.
34. Kaetzel C. S., Robinson J. K., Chintalacharuvu K. R., Vaerman J.-P., Lamm M. E. The polymeric immunoglobulin receptor mediates transport of immune complexes across epithelial cells: A local defense function for IgA. Proc. Natl. Acad. Sci. USA. 88:1991;8796-8800.
35. Kubo H., Yamada Y. K., Taguchi F. Localization of neutralizing epitopes and the receptor binding site within the amino-terminal 330 amino acids of the murine coronavirus spike glycoprotein. J. Virol. 68:1994;5403-5410.
36. Kurilla M. G., Keene J. D. The leader RNA of vesicular stomatitis virus is bound by a cellular protein reactive with anti-La lupus antibodies. Cell. 34:1983;837-845.
37. Lai M. M. C. Coronaviruses: Organization, replication and expression of the genome. Annu. Rev. Microbiol. 44:1992;303-333.
38. Levine B., Huang Q., Isaacs J. T., Reed J. C., Griffin D. E., Hardwick J. M. Conversion of lytic to persistent alphavirus infection by the Bcl-2 oncogene. Nature. 361:1993;739-742.
39. Levine B., Goldman J. E., Jiang H. H., Griffin D. E., Hardwick J. M. Bcl-2 protects mice against fatal alphavirus encephalitis. Proc. Natl. Acad. Sci. USA. 93:1996;4810-4815.
40. Levine B., Hardwick J. M., Trapp B. D., Crawford T. O., Bollinger R. C., Griffin D. E. Antibody-mediated clearance of alphavirus infection from neurons. Science. 254:1991;856-860.
41. Lin S-H., Gudotti G. Cloning and expression of a cDNA coding for a rat liver plasma membrane ecto-ATPase. J. Biol. Chem. 264:1989;14408-14414.
42. Locker J. K., Rose J. K., Horzinek M. C., Rottier P. J. Membrane assembly of the triple-spanning coronavirus M protein. Individual transmembrane domains show preferred orientation. J. Biol. Chem. 267:1992;21911-21918.
43. Luytjes W., Bredenbeek P. J., Noten A. F. H., Horzinek M. C., Spaan W. J. M. Sequence of mouse hepatitis virus A59 mRNA2: Indications for RNA recombination between coronavirus and influenza C virus. Virology. 166:1987;415-422.
44. Malo D., Skamene E. Genetic control of host resistance to infection. Trends Genet. 10:1994;365-371.
45. Mazanec M. B., Kaetzel C. S. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA. 89:1992;6901.
46. Mazanec M. B., Coudret C. L., Fletcher D. R. Intracellular neutralization of influenza virus by immunoglobulin A antihemagglutinin monoclonal antibodies. J. Virol. 69:1995;1339.
47. McCuaig K., Rosenberg M., Nedellec P., Turbide C., Beauchemin N. Expression of theBgp. Gene. 127:1993;173-183.
48. McKeating J. A., Balfe P., Clapham P. R., Weiss R. A. Recombinant soluble CD4 selected HIV-1 variants with reduced env affinity for CD4 and increased cell fusion ability. J. Virol. 65:1991;4777-4785.
49. Nedellec P., Dveksler G. S., Daniels E., Turbide C., Chow B., Basile A. A., Holmes K. V., Beauchemin N. Bgp2, J. Virol. 68:1994;4525-4537.
50. Olson K. E., Higgs S., Gaines P. J., Powers A. M., Davis B. S., Kamrud K. I., Carlson J. O., Blair C. D., Beaty B. J. Genetically engineered resistance to Dengue 2 virus transmission in mosquitoes. Science. 272:1996;884-886.
51. Oshiro L. S. Coronaviruses. Dalton A. J. F., Haguenau. Ultrastructure of Animal Viruses and Bacteriophages: An Atlas. 1973;331-343 Academic Press, New York.
52. Pachuk C., Bredenbeek P. J., Zoltick P. W., Spaan W. J. M., Weiss S. R. Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59. Virology. 171:1989;141-148.
53. Pavlovic J., Haller O., Staeheli P. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 66:1992;2564-2569.
54. Richard C. S., Koetzner C. A., Sturman L. S., Masters P. S. A conditional lethal murine coronavirus A59 ts mutant fails to incorporate the spike glycoprotein into assembled virions. Virus Res. 39:1995;261-276.
55. Rosenberg M., Nedellec P., Jothy S. S., Fleiszer D., Turbide C., Beauchemin N. The expression of mouse biliary glycoprotein, a carcinoembryonic antigen-related gene, is down-regulated in malignant mouse tissues. Cancer Res. 53:1993;4938-4945.
56. Sarver N., Cantin E. M., Chang P. S., Zaia J. A., Ladne P. A., Stephens D. A., Rossi J. J. Ribozymes as potential anti-HIV-1 therapeutic agents. Science. 247:1990;1222-1225.
57. Schaad M. M. C., Stohlman S. A., Egbert J., Lum K., Wei T., Baric R. S. Genetics of MHV transcription: Identification of cistrons which may function in positive and negative strand RNA synthesis. Virology. 196:1990;190-198.
58. Shaheen F., Duan L., Zhu M., Bagasra O., Pomerantz R. J. Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle. J. Virol. 70:1996;3392-3400.
59. Siess D. C., Kozak S. L., Kabat D. Exceptional fusiogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process. J. Virol. 70:1996;3432-3439.
60. Sturman L., Holmes K. The novel glycoproteins of coronaviruses. Trends Biochem. Sci. 10:1985;17-20.
61. Suzuki H., Taguchi F. Analysis of the receptor-binding site of murine coronavirus spike glycoprotein. J. Virol. 70:1996;2632-2636.
62. Tooze J., Tooze S. A., Warren G. Replication of coronavirus MHV-A59 in sac- cells: Determination of the first site of budding of progeny virions. Eur. J. Cell Biol. 33:1984;281-293.
63. Tooze J., Tooze S. A. Infection of AtT20 murine pituitary tumor cells by mouse hepatitis virus strain A59: Virus budding is restricted to the golgi region. Eur. J. Cell Biol. 37:1985;303-312.
64. Ubol S., Tucker P. C., Griffin D. E., Hardwick J. M. Neurovirulent strains of alphavirus induce apoptosis in Bcl-2 expressing cells: Role of a single amino acid change in the E2 glycoprotein. Proc. Natl. Acad. Sci. USA. 91:1991;5202-5296.
65. Vennema H., Godeke G-J., Rossen J. W. A., Voorhout W. F., Horzinek M. C., Opstelten D-J., Rottier P. J. M. Nucleocapsid-independent assembly of coronavirus-like particles by coexpression of viral envelope protein genes. EMBO J. 15:1996;2020-2028.
66. Wang K.-S., Kuhn R. J., Strauss E. G., Ou S., Strauss J. H. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J. Virol. 66:1992;4992-5001.
67. Weber J. Blocks on the viral exit. Nature (London). 345:1990;573-574.
68. Weiss R. A. Cellular receptors and viral glycoproteins involved in retrovirus entry. Levy J. A. The Retroviridae. 1993;1-108 Plenum, New York.
69. Williams R. K., Jiang G.-S., Snyder S. W., Frana M. F., Holmes K. V. Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice. J. Virol. 64:1990;3817-3823.
70. Yeager C. L., Ashmun R. A., Williams R. K., Cardellichio C. B., Shapiro L. H., Look A. T., Holmes K. V. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature (London). 357:1992;420-422.
71. Yokomori K., Asanaka M., Stohlman S. A., Lai M. M. C. A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry. Virology. 196:1993;45-56.
72. Yokomori K., Lai M. M. C. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J. Virol. 66:1992;6194-6199.
73. Yu X., Weiss S. R., Leibowitz J. L. Mouse hepatitis gene 5b is a new virion envelope glycoprotein. Virology. 202:1994;1018-1023.
74. Zhang X. M., Lai M. M. C. Interactions between the cytoplasmic proteins and intergenic sequence of mouse hepatitis virus RNA: Correlation with the amount of subgenomic mRNA transcribed. J. Virol. 69:1995;1637-1644.
75. Zhang X. M., Lai M. M. C. Regulation of coronavirus RNA transcription is likely mediated by protein-RNA interactions. Adv. Exp. Med. Biol. 380:1995b;515-522.